Ligand's (LGND) Duavee Will be Significant N-T Revenue Driver; CHMP Opinion is Encouraging - Roth Oct 24, 2014 11:15AM
Roth 'Encouraged' by Verastem's (VSTM) VS-6063 Effect on Biomarkers of CSCs Oct 24, 2014 10:54AM
Roth Capital Downgrades IGI Laboratories (IG) to Neutral Oct 24, 2014 08:18AM
Roth Capital 'Encouraged' by Cytori (CYTX) Receiving FDA Approval to Continue ATHENA Oct 23, 2014 02:04PM
Roth Capital Lifts PT on Ligand (LGND) 32% Ahead of Q3 Results Oct 23, 2014 08:45AM
View Older Stories

Oct 23, 2014 07:00AM Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
Oct 22, 2014 08:40AM Roth Affirms Ligand (LGND) at 'Buy' Following Strong Promacta Sales in Q3
Oct 20, 2014 12:53PM Unusual 11 Mid-Day Movers 10/20: (SCOK) (ESI) (SHOR) Higher; (IBIO) (NCR) (CPXX) Lower
Oct 20, 2014 09:59AM Roth Capital Maintains Cytokinetics (CYTK) at 'Buy' Following BENEFIT-ALS Update
Oct 17, 2014 03:31PM Roth Capital Remains Bullish on Hudson Technologies (HDSN); EPA Ruling 'Materially' Better than Expected
Oct 17, 2014 12:59PM Celator Pharmaceuticals (CPXX) Plans Common Stock, Warrants Offering
Oct 17, 2014 12:57PM Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock
Oct 17, 2014 12:57PM Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock
Oct 17, 2014 09:24AM Roth Boosts PT on Pharmacyclics (PCYC) to $188; Imbruvica Continues to Gain Traction
Oct 17, 2014 09:01AM Roth Capital Remains Positive on Regeneron (REGN); Latest Outcome Better Positions Eylea as Superior DME Treatment
Oct 16, 2014 05:04PM Hannon Armstrong Sustainable Infrastructure Capital, Inc. to Participate in the ROTH Capital Partners Solar Symposium on October 22, 2014
Oct 16, 2014 02:36PM Enphase Energy to Host Analyst Day and Participate at ROTH Capital Partners Solar Symposium on October 22, 2014
Oct 16, 2014 02:22PM Roth Capital Positive on Curis (CRIS) Following Q3 Results from Roche/Erivedge
Oct 16, 2014 11:00AM The Joint Corp. Files Registration Statement for Proposed Initial Public Offering
Oct 16, 2014 07:53AM Roth Capital Adds MEI Pharma (MEIP) to Focus List; Multiple Key Inflection Points Coming
Oct 15, 2014 06:54AM Roth Capital Downgrades Durata Therapeutics (DRTX) to Neutral
Oct 14, 2014 03:38PM BioNJ’s 2nd Annual CEO Summit on October 20-21 Charts the Course for Success
Oct 14, 2014 09:00AM ROTH Capital Partners to Host Solar Symposium at Solar Power International (SPI 14)
Oct 14, 2014 07:20AM Roth Capital Starts The Hackett Group (HCKT) at Buy
Oct 13, 2014 11:52AM New Pharmacyclics (PCYC) Collaboration Further Validates Imbruvica; Roth Boosts PT to $185
Oct 13, 2014 09:26AM Roth Sees Visibility in Cytokinetics' (CYTK) CK-107 Program Increasing Significantly Moving Forward
Oct 13, 2014 08:41AM NCE Status Won't Matter for Keryx Biopharma (KERX) - Roth Capital
Oct 10, 2014 04:11PM Cytori Therapeutics (CYTX) Closes on $13.5M in Financing
Oct 10, 2014 04:05PM Cytori Therapeutics, Inc. Announces Closing of Financing
Oct 10, 2014 10:55AM Notable Analyst Rating Changes 10/10: (IPXL) (EA) (AON) Upgraded; (JCP) (GRPN) (BDSI) Downgraded
Oct 10, 2014 07:10AM Roth Capital Resumes XOMA, Ltd. (XOMA) at Buy
Oct 10, 2014 06:36AM Roth Capital Downgrades BioDelivery Sciences International (BDSI) to Neutral
Oct 9, 2014 05:30PM ARI Network Services, Inc. Announces the Appointment of Chad J. Cooper to Board of Directors
Oct 9, 2014 05:30PM ARI Network Services, Inc. Announces the Appointment of Chad J. Cooper to Board of Directors
Oct 9, 2014 11:50AM Roth Positive on SolarCity's (SCTY) Loan Program; Sees Tail Risks Ebbing
Oct 9, 2014 06:36AM Roth Capital Upgrades Golden Minerals Company (AUMN) to Buy
Oct 8, 2014 11:33AM PlacementTracker Publishes Third Quarter 2014 PIPE Market League Tables
Oct 8, 2014 11:33AM PlacementTracker Publishes Third Quarter 2014 PIPE Market League Tables
Oct 8, 2014 08:06AM Cytori Therapeutics (CYTX) Announces $13.5M Registered Direct Placement
Oct 8, 2014 08:00AM Cytori Therapeutics, Inc. to Raise $13.5 Million in Registered Direct Offering
Oct 7, 2014 12:23PM Roth Capital Cuts SodaStream International (SODA) to Neutral
Oct 7, 2014 10:56AM Notable Analyst Rating Changes 10/7: (IR) (ADHD) (AAPL) Upgraded; (SNSS) (DE) (CBSH) Downgraded
Oct 7, 2014 09:00AM ROTH Capital Partners Expands Cleantech and Industrial Growth Practice with Addition of Gerry Sweeney, Senior Research Analyst, Environmental Services
Oct 7, 2014 07:49AM Roth Keeps Regeneron (REGN) at 'Buy'; Another Eylea Approval is No Surprise
Oct 7, 2014 07:13AM Roth Capital Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Neutral
Oct 6, 2014 04:40PM Trina Solar (TSL) Closes 10.3M ADS, $115M Conv. Notes Offerings
Oct 6, 2014 04:30PM Trina Solar Announces Closing of 10,333,785 American Depositary Shares
Oct 6, 2014 09:43AM Roth Capital Affirms SolarCity (SCTY) at 'Buy'; Comments on Recent Meetings with Management
Oct 6, 2014 06:30AM Roth Capital Starts ContraFect Corp. (CFRX) at Buy; Market Missing Potential Impact of Bacteriophage Lysins
Oct 3, 2014 08:35AM Titan Pharmaceuticals Announces Pricing of Public Offering
Oct 2, 2014 09:39AM Recent Moves by Curis (CRIS) May Increase Value of CUDC-907 - Roth Capital
Oct 1, 2014 09:11AM Trina Solar (TSL) Prices 10.3M ADS, $100M Conv. Notes Offering
Oct 1, 2014 09:10AM Trina Solar Announces Pricing of Offering of 10,333,785 American Depositary Shares
Oct 1, 2014 07:50AM Lerge Commercial Exit by RGS Energy (RGSE) is 'Right Move' - Roth
Sep 30, 2014 10:44AM Latest Data for Regeneron's (REGN) Dupilumab Broadens Benefit Profile - Roth
View Older Stories